- Home
- GAIA vs BYSI Comparison
GAIA vs BYSI Comparison
Compare GAIA & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GAIA | BYSI |
|---|---|---|
| Founded | 1988 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.9M | 79.0M |
| IPO Year | 1999 | 2017 |
Fundamental Metrics
Financial Performance| Metric | GAIA | BYSI |
|---|---|---|
| Price | $3.86 | $1.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | 100.6K | ★ 115.8K |
| Earning Date | 11-03-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $98,622,000.00 | N/A |
| Revenue This Year | $11.55 | N/A |
| Revenue Next Year | $11.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.80 | N/A |
| 52 Week Low | $2.93 | $0.98 |
| 52 Week High | $6.39 | $3.44 |
Technical Indicators
Market Signals| Indicator | GAIA | BYSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.13 | 45.05 |
| Support Level | $3.65 | $1.55 |
| Resistance Level | $3.99 | $1.77 |
| Average True Range (ATR) | 0.23 | 0.13 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 59.18 | 60.87 |
Price Performance
Historical ComparisonAbout GAIA Gaia Inc.
Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.